The Cooper Companies found using ticker (COO) have now 12 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price and low target price is between 380 and 300 with the average target price sitting at 344.58. With the stocks previous close at 334.04 this is indicating there is a potential upside of 3.2%. The 50 day moving average now sits at 338.38 and the 200 day MA is 315.7. The market capitalisation for the company is $17,848m. You can visit the company’s website by visiting: http://www.coopercos.com
The Cooper Companies operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians’ and gynecologists’ (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive option, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies was founded in 1980 and is based in San Ramon, California.
You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.